Xiaolun Wang
About Xiaolun Wang
Xiaolun Wang serves as the Senior Director of Chemistry at Mirati Therapeutics, a position he has held since 2019. He earned his Ph.D. from Columbia University and has extensive experience in the pharmaceutical industry, including roles at Takeda and Pfizer.
Work at Mirati Therapeutics
Xiaolun Wang currently serves as the Senior Director of Chemistry at Mirati Therapeutics. He has held this position since 2019, contributing to the company's research and development efforts in the field of oncology. His role involves overseeing chemistry projects and leading a team focused on drug discovery and development. The Greater San Diego Area serves as the operational base for his work at Mirati Therapeutics.
Previous Experience at Takeda San Diego, Inc.
Before joining Mirati Therapeutics, Xiaolun Wang worked at Takeda San Diego, Inc. for a total of eight years. He began as a Senior Scientist from 2011 to 2016, where he was involved in various projects related to drug development. He then advanced to the position of Principal Scientist from 2016 to 2019, further enhancing his expertise in the pharmaceutical industry.
Experience at Pfizer
Xiaolun Wang also has significant experience from his tenure at Pfizer, where he worked as a Principal Scientist from 2005 to 2011. During this six-year period, he contributed to various research initiatives and played a role in advancing the company's pharmaceutical projects.
Education and Expertise
Xiaolun Wang earned his Ph.D. from Columbia University in the City of New York, where he studied from 2000 to 2005. Prior to that, he completed his Bachelor of Science degree at Nanjing University from 1992 to 1996. His educational background has equipped him with a strong foundation in chemistry and drug development, which he applies in his current and previous roles.